comparemela.com

Latest Breaking News On - Catalent biomodalities - Page 1 : comparemela.com

Catalent, Inc Reports Second Quarter Fiscal 2024 Results

Q2 24 net revenue of $1.03 billion decreased 10% as reported, or 11% in constant currency, compared to Q2 23. Q2 24 net revenue, excluding COVID-related revenue of ~$260 million in Q2’23 and.

Catalent, Inc Reports Second Quarter Fiscal 2024 Results

Catalent, Inc Reports Second Quarter Fiscal 2024 Results
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

Catalent (CTLT) Reports Prelim Q3 Revenue of $982M, EPS of ($0 10), Reaffirms FY24 Guidance

Catalent (CTLT) Reports Prelim Q3 Revenue of $982M, EPS of ($0 10), Reaffirms FY24 Guidance
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.